Navigation Links
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
Date:6/29/2009

FRANKLIN LAKES, N.J., June 29 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its third fiscal quarter 2009 earnings conference call on Thursday, July 30, 2009 at 10:00 a.m. (EDT). BD will issue a press release detailing the quarter's earnings earlier that morning.

The webcast of the conference call, along with related slides, will be accessible through BD's website at www.bd.com/investors and will be available for replay through Thursday, August 6, 2009.

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 counties throughout the world. The company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.

    Contact Information:
    Patricia A. Spinella, Investor Relations - 201-847-5453
    Colleen T. White, Corporate Communications - 201-847-5369


'/>"/>
SOURCE BD (Becton, Dickinson and Company)
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , REYKJAVIK, Iceland, November 24 ...asdaq: DCGN ) today announced that it has received...in the company,s common stock will be,suspended as...led with the,Securities and Exchange Commission, w...g on Nasdaq, unless the company files an appeal to...
(Date:11/24/2009)..., SAN MATEO, Calif., Nov. 24 /PRNewswire-FirstC...rmaceutical company focused on developing and comm...nced today that Anthony DiTonno, President and Chi...he 21st Annual Piper Jaffray Health Care Conferenc...alace Hotel in New York, New York. ,, Mr. DiTo...
(Date:11/24/2009)..., TSX VENTURE: HTL , TORONTO, Nov. 24 /PRNews...), formerly Calotto Capital Inc., a leading provid...he stem cell research and fertility clinic markets... for the third quarter ended September 30, 2009. ,...46 million compared with $1.43 million in Q3 2008,...
(Date:11/24/2009)... Program Connects Customers with Par...lected with DNA Genotek Products , ... DNA Genotek , a leading provider of products for ...eparation, today announced its new global partner ...ts for DNA Genotek,s partner community and is desi...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...t. 15 Symmetry Medical Inc.,(NYSE: SMA ), a lead...,orthopedic device industry and other medical mark...t and Chief Executive Officer, is scheduled to,pre... The Grand Hyatt New,York in New York City on Thur...e Web cast of the presentation will be available o...
... Sept. 15 Assay Designs and the Spinal,Muscular A...nce a,collaborative agreement for development of r... protein to expedite drug discovery and developmen...eading genetic cause of,mortality in infants and t...ve been selected by the SMA Foundation, and to hel...
...5 Enobia Pharma, an emerging biotech,company focu...one,disorders, presented pre-clinical data demonst...or hypophosphatasia appears to heal bones that,hav...arlier pre-clinical,data showed that ERT with Enob...vival and prevents bone hypomineralization associa...
Other Biology Technology:Symmetry Medical to Present at UBS Global Life Sciences Conference 2Assay Designs(TM), Inc. and the Spinal Muscular Atrophy Foundation Announce Collaboration To Accelerate the Discovery of New Therapeutics for Spinal Muscular Atrophy (SMA) 2Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice 2Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice 3
(Date:11/24/2009)...a matter of debate. A high-profile study a few yea...f their carbon from trees and leaves, evidence for...atic ecosystems. , But new research from the Uni...be true. Algae provide a much richer diet for fish...lished this week in the Proceedings of the Nation...
(Date:11/23/2009)...23, 2009 Applied mathematicians dissected the mor... a characteristic long leaf with a saddle-like arc...dges. The simple cause of the lily,s fan-like shap...differential growthwas revealed by using an equall...aiyi Liang, a postdoctoral student at Harvard,s Sc...
(Date:11/23/2009)...provides "incontrovertible evidence" that the volc...ra about 73,000 years ago deforested much of centr...earchers report. , The volcano ejected an estima...e, leaving a crater (now the world,s largest volca...eters wide. Ash from the event has been found in I...
Breaking Biology News(10 mins):Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3The cause behind the characteristic shape of a long leaf revealed 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review 49849 1Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review 49849 2Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review 49849 3Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review 49849 4New theraplex SA FACIAL PEEL Shows True Colors at Cosmetic Boot Camp 49847 1New theraplex SA FACIAL PEEL Shows True Colors at Cosmetic Boot Camp 49847 2Micro Businesses Offer Strong Opinions On Health Reform Proposals 49845 1Micro Businesses Offer Strong Opinions On Health Reform Proposals 49845 2Micro Businesses Offer Strong Opinions On Health Reform Proposals 49845 3Micro Businesses Offer Strong Opinions On Health Reform Proposals 49845 4
...st clinical evidence that gene therapy reduces sym...portant milestone for this promising treatment whi...ed in the February issue of the journal Human Gen...atients with severe rheumatoid arthritis conducted...ael Deaconess Medical Center (BIDMC). , Original...
...globe, the demand for water is increasing with the...reas are requiring more water for drinking, sanita...n water supplies. In addition, depleting ground wa...hange have led to an increased importance for the ...ent water pollution, and efficiently allocate wate...
...thousands of lives a year, University of Utah Scho... vessel disorder leading to unpredictable, sometim... or other problems is treatable with the same stat...igh cholesterol. , If the results of a study in m...atins could provide a safe, inexpensive treatment ...
Other Biology News:Gene therapy demonstrates benefit in patients with rheumatoid arthritis 2Gene therapy demonstrates benefit in patients with rheumatoid arthritis 3How to move agriculture forward with limited water 2Statins may treat blood vessel disorder that can lead to fatal strokes 2Statins may treat blood vessel disorder that can lead to fatal strokes 3
...s constitute the principal excitatory neurotransmi...receptors exist: Ionotropic receptors, and metabot...e oligomeric complexes of various subunits (GluR1-...cium channels. Metabotropic glutamate receptors ar...
PIP Beads di-C6 PtdIns(4,5)P2 from Echelon Biosciences Inc.
Mouse Anti-D-Dimer Antibody, Unconjugated from HyTest Ltd.
...ogen corresponds to amino acids 2-105 from human S...has been successfully used in Western blot, immuno... By Western blot, this antibody detects an ~ 60 kD...s also been used in immunoprecipitation and immuno...
Biology Products: